Previous studies have found disruptions of the rhythmic expression of PER1, PER2, CRY1, BMAL1, NPAS2, and GSK-3b in MDD, which might influence the susceptibility to recurrence after antidepressant treatment (32). The gene discussed is PER1; the disease is major depressive disorder.